The Lataster Ecological Study on COVID-19 Vaccination and Excess Mortality in Australia

The recent ecological study (observation of a group), led by Raphael Lataster, published in the International Journal of Risk and Safety in Medicine, https://journals.sagepub.com/doi/10.1177/09246479261446501, presents a profound challenge to the official narrative that mass COVID-19 vaccination programs were unequivocally safe and effective. By examining four Australian regions, Queensland, Western Australia, South Australia, and the Northern Territory, the study concludes that the rollout of COVID-19 vaccines was correlated with a statistically significant rise in excess mortality, despite these regions experiencing relatively low COVID-19 case counts and shorter lockdowns. This finding aligns with a growing body of evidence suggesting that the risks associated with these novel genetic interventions may have been systematically understated, while their benefits were exaggerated by public health authorities and pharmaceutical interests.

The Lataster study employs an ecological design, comparing population-level vaccination rates against all-cause mortality data, which is a standard epidemiological tool for detecting population-wide signals of harm or benefit. Critics often dismiss ecological studies as unable to prove causation, a limitation acknowledged by the authors. However, in the context of evaluating a mass medical intervention rolled out across entire populations, with no control group of unvaccinated individuals, such population-level analyses are often the most ethical and practical means of detecting adverse signals that may be missed by randomised controlled trials or hospital-based studies. As the study highlights, the temporal correlation between the escalation of the vaccination campaign and the rise in excess deaths, particularly in regions with minimal COVID-19 circulation, is striking and demands rigorous investigation.

The study's focus on regions with "low COVID-19 case counts" is methodologically critical. If excess deaths were primarily driven by the virus itself, we would expect to see the highest mortality in areas with the most infections. Instead, the Lataster paper reports that excess deaths in parts of Australia rose in concert with vaccination coverage, even when the virus was not widely circulating. This pattern directly contradicts the official justification for the vaccines, which was to prevent severe illness and death from COVID-19. When excess mortality occurs in the absence of the target disease, it suggests the intervention itself may be the causative factor. This mirrors concerns raised about the VAERS database in the United States, which has recorded hundreds of thousands of adverse event reports following COVID-19 vaccination, including myocarditis, thrombocytopenia, and sudden cardiac arrest in young people, conditions that were extremely rare prior to 2021.

To understand how a vaccine could contribute to excess mortality, we must examine the known biological mechanisms of the spike protein and the lipid nanoparticle delivery system used in the mRNA vaccines. The spike protein, which the body is instructed to produce, is not a harmless antigen. It is a pathogenic protein that, in its natural form within the SARS-CoV-2 virus, is responsible for binding to ACE2 receptors and mediating cellular entry. Multiple studies have shown that the spike protein alone can cause endothelial damage, disrupt mitochondria function, and promote blood clotting. This is not a theoretical concern; pre-clinical animal studies conducted by Pfizer (released only after litigation) demonstrated that the lipid nanoparticles can migrate from the injection site to the ovaries, liver, spleen, and brain, accumulating in these tissues and causing inflammation. Furthermore, the spike protein itself has been detected in the bloodstream months after vaccination, indicating persistent antigen production that could drive chronic inflammation and autoimmune reactions.

The Lataster study's findings are therefore biologically plausible. The significant rise in excess deaths in Australia, particularly among working-age adults, is consistent with the hypothesis that the vaccines are inducing a delayed toxic effect. Conditions such as vaccine-induced immune thrombotic thrombocytopenia (VITT), myocarditis/pericarditis, and strokes have been documented in the post-marketing surveillance data of all authorised COVID-19 vaccines. The fact that these events often occur days to weeks after vaccination, and may be undercounted in official mortality statistics if deaths are attributed to "cardiac arrest" or "sudden death" without investigation of vaccination history, fits the pattern observed in the Australian data. The study suggests that the true number of vaccine-related fatalities may be far higher than what is captured in passive surveillance systems like the VAERS or the Australian TGA's adverse event reporting.

The Lataster paper must be understood within the context of a global campaign to suppress or discredit any evidence that undermined the emergency use authorisation narrative. Throughout 2020-2023, governments, media outlets, and even academic journals exhibited a lockstep refusal to publish or seriously discuss data indicating vaccine harms. The FDA and CDC were repeatedly accused of failing to conduct their own rigorous safety studies, instead relying on manufacturer-provided data that was never fully transparent. The "excess mortality" phenomenon is not unique to Australia; similar spikes have been documented in the United States, the United Kingdom, Canada, Germany, and Israel.

In the United States, the CDC's own data from the National Center for Health Statistics reveals that excess deaths among the 15-59 age group skyrocketed in 2021, precisely when the vaccine rollout was most aggressive. Yet the CDC has refused to acknowledge a causal link, instead attributing the deaths to "underlying conditions" or "delayed care" during the pandemic—explanations that feel increasingly hollow as the Lataster study shows similar patterns in regions with short lockdowns and low COVID-19 burden. The institutional capture of public health agencies by the pharmaceutical industry has created a profound conflict of interest. The very bodies that approved and promoted the vaccines are now tasked with investigating their potential harms. This is a classic scenario of the fox guarding the henhouse.

The Lataster study is not surprising; it is a late-confirmation of data that has been accumulating for years. The implications for public policy are severe. If even a portion of the excess deaths in Australia can be attributed to vaccination, then the risk/benefit calculus that drove mandates and booster campaigns was fundamentally flawed. This is particularly concerning for healthy young people, for whom the risks of severe COVID-19 were always extremely low, but the risks of vaccine-induced myocarditis or clotting events were demonstrably higher. The study argues that the vaccination campaign in Australia, far from saving lives, may have actually increased mortality in the very populations it was intended to protect.

The Lataster ecological study provides compelling evidence that the COVID-19 vaccination campaign in Australia was temporally associated with a significant rise in excess all-cause mortality, a finding that aligns with biological plausibility and with data from other nations. The study calls into question the integrity of the regulatory process that approved these vaccines, the veracity of official safety data presented to the public, and the wisdom of ongoing booster campaigns, still continuing.